13-113122816-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000504.4(F10):c.-40C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0342 in 1,603,172 control chromosomes in the GnomAD database, including 1,151 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.028 ( 94 hom., cov: 33)
Exomes 𝑓: 0.035 ( 1057 hom. )
Consequence
F10
NM_000504.4 5_prime_UTR_premature_start_codon_gain
NM_000504.4 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.54
Genes affected
F10 (HGNC:3528): (coagulation factor X) This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 13-113122816-C-T is Benign according to our data. Variant chr13-113122816-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 311266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0277 (4215/152360) while in subpopulation NFE AF = 0.0415 (2824/68030). AF 95% confidence interval is 0.0402. There are 94 homozygotes in GnomAd4. There are 2128 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 94 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F10 | ENST00000375559 | c.-40C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 8 | 1 | NM_000504.4 | ENSP00000364709.3 | |||
F10 | ENST00000375559 | c.-40C>T | 5_prime_UTR_variant | Exon 1 of 8 | 1 | NM_000504.4 | ENSP00000364709.3 |
Frequencies
GnomAD3 genomes AF: 0.0277 AC: 4217AN: 152242Hom.: 95 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
4217
AN:
152242
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0273 AC: 6673AN: 244618 AF XY: 0.0275 show subpopulations
GnomAD2 exomes
AF:
AC:
6673
AN:
244618
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0349 AC: 50627AN: 1450812Hom.: 1057 Cov.: 31 AF XY: 0.0344 AC XY: 24874AN XY: 722292 show subpopulations
GnomAD4 exome
AF:
AC:
50627
AN:
1450812
Hom.:
Cov.:
31
AF XY:
AC XY:
24874
AN XY:
722292
Gnomad4 AFR exome
AF:
AC:
174
AN:
33408
Gnomad4 AMR exome
AF:
AC:
394
AN:
44698
Gnomad4 ASJ exome
AF:
AC:
264
AN:
26120
Gnomad4 EAS exome
AF:
AC:
0
AN:
39674
Gnomad4 SAS exome
AF:
AC:
1005
AN:
86206
Gnomad4 FIN exome
AF:
AC:
2795
AN:
45748
Gnomad4 NFE exome
AF:
AC:
44325
AN:
1108972
Gnomad4 Remaining exome
AF:
AC:
1636
AN:
60226
Heterozygous variant carriers
0
2633
5265
7898
10530
13163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1594
3188
4782
6376
7970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0277 AC: 4215AN: 152360Hom.: 94 Cov.: 33 AF XY: 0.0286 AC XY: 2128AN XY: 74498 show subpopulations
GnomAD4 genome
AF:
AC:
4215
AN:
152360
Hom.:
Cov.:
33
AF XY:
AC XY:
2128
AN XY:
74498
Gnomad4 AFR
AF:
AC:
0.00627494
AN:
0.00627494
Gnomad4 AMR
AF:
AC:
0.0175702
AN:
0.0175702
Gnomad4 ASJ
AF:
AC:
0.0129608
AN:
0.0129608
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00868846
AN:
0.00868846
Gnomad4 FIN
AF:
AC:
0.0681304
AN:
0.0681304
Gnomad4 NFE
AF:
AC:
0.0415111
AN:
0.0415111
Gnomad4 OTH
AF:
AC:
0.0160681
AN:
0.0160681
Heterozygous variant carriers
0
209
418
627
836
1045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Factor VII deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Factor X deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=300/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at